Importance: To determine if endophthalmitis following cataract surgery is linked to increased mortality.
INTRODUCTION
Endophthalmitis following cataract surgery is recognized as a sight-threatening complication occurring in approximately 1 in 1000 cases. [1] [2] [3] The risk is greater when the cataract surgery is complicated and in patients with co-existing morbidities, such as diabetes and immune-compromised states. [4] [5] [6] In terms of patient outcomes, multiple studies have utilized visual function as a primary end-point, although other ocular parameters, including phthisis and retinal detachment, have also been reported. Adverse variables link virulent organisms, the presence of a hypopyon, gram-negative bacteria and poor presenting visual acuity and delayed presentation with increased ocular morbidity.
To date, no study has documented any relationship between post-cataract endophthalmitis and mortality, although some reports have linked endogenous endophthalmitis and increased risk of premature death. 10, 11 We hypothesize that the predisposition to, or systemic burden of, developing post-cataract endophthalmitis may be associated with increased mortality. In this study, we aim to investigate survival rates for patients undergoing cataract surgery who developed endophthalmitis postoperatively compared to a matched population of subjects that did not develop endophthalmitis following cataract surgery.
METHODS
This case-control study comprised consecutive patients who developed endophthalmitis following cataract surgery in the 10-year period from April 2004 to December 2014. The patients were identified from a prospective electronic surgical database that records all ophthalmic procedures and interventions performed at our public hospital institution (Department of Ophthalmology, Greenlane Clinical Centre, Auckland District Health Board). This facility also acts as the regional referral centre for all cases of presumed endophthalmitis. Patients having a vitreous or anterior chamber tap or vitreous biopsy were reviewed along with any patient being administered an intravitreal injection of antibiotics. The clinical notes for this patient group were accessed and individually searched specifically for a history of recent cataract surgery -defined as less than 6 weeks. The subset that underwent recent cataract surgery was further assessed in relation to a history of diabetes and hypertension. In New Zealand, there is a national database that records demographic and health-related data on all New Zealand residents. This enabled us to determine if the patient was alive at the time of sequestration (September 2015). If the patient were deceased, the date of death was recorded. The national database also includes a category for recording all subsidized pharmaceuticals (which are universally available for all New Zealand residents), therefore facilitating a crosscheck on existing comorbidities.
A well-documented control group was identified from the same centre that comprised of 500 patients who had undergone cataract surgery between February 2000 and December 2000. 12 The patients' medical histories have been contemporaneously recorded in detail at the time of the original cataract surgery, and this information was accepted without further review. The national electronic database was accessed to determine the date of death for any individual in this cohort or if the patient was still alive at the time of sequestration.
Data entry and statistical analysis
The patients' demographics, including age and gender, were recorded on a spreadsheet, together with the selected medical comorbidities. The date of death or survival was measured in terms of the number of months following cataract surgery. Patients who survived to September 2015 were censored, and their survival was calculated from the day of surgery to September 2015.
Those patients developing endophthalmitis following cataract surgery as well as the control group were plotted on a series of Kaplan-Meier graphs, according to the pre-selected variables, and analysed in terms of survival. Statistical analysis was performed using SPSS software, version 22 (SPSS GmbH Software, Munich, Germany). Each case was matched to two controls based on age (fuzz factor 10), gender, presence of diabetes and hypertension. The log-rank (Mantel-Cox) test was used to determine a statistically significant difference between Kaplan-Meier survival curves. P values less than 0.05 were considered statistically significant.
RESULTS
Fifty patients were initially diagnosed with exogenous endophthalmitis following cataract surgery over the 10-year period. However, this total number was revised to 48 as 2 patients were excluded: one because an intravitreal injection of a steroid suspension was performed at the time of cataract surgery and the other because cataract surgery was combined with a vitrectomy. The rate of post-cataract endophthalmitis for the region over the 10-year period approximated to 1 in 1200.
Of the 48 patients included, mean age was 70 years AE12 SD, with a female predominance of 30:18. Eight patients were diabetic (17%), whereas 24 (50%) were diagnosed with hypertension. Sixteen (33%) patients were deceased by the time of sequestration, with the mean time to death following cataract surgery being 59 months.
In the control group of 500 cases, one patient was excluded because of post-cataract endophthalmitis, and another 34 had incomplete data and/or the time of death or survival could not be accurately determined. Of the remaining 465 patients (n = 465), the mean age was 75 years AE10 SD, with 63% female. In this comparison group, compared to the study group, a similar percentage exhibited diabetes mellitus (20% vs. 17%, P = 0.604), but a smaller percentage had systemic hypertension (26% vs. 50%, P = 0.001). The median time to death in this control group was 81 months, and 71% (n = 328) were deceased at sequestration, approximately 15 years after cataract surgery.
From the control group (n = 465), 96 cases were matched, two each, to the 48 cases of endophthalmitis for age, gender and presence or absence of diabetes or hypertension. We found no statistically significant difference in median survival between these matched controls without endophthalmitis and the cases with endophthalmitis (100 months vs. 106 months, respectively, P = 0.756). Furthermore, there was no statistically significant difference in terms of survival for 60% of the individuals in each group (85 months for patients with endophthalmitis and 83 months for the control group) (Fig. 1) .
Thirty-one patients with a diagnosis of postcataract endophthalmitis were culture-positive, equating to 65% of cases. The microbial diagnosis is provided in Table 1 . The median survival for culture-positive patients was 86 months, whereas the culture-negative group had a median survival of 106 months, although this difference was not statistically significant (P = 0.072) (Fig. 2) .
DISCUSSION
Significant visual loss is well documented following cataract surgery complicated by endophthalmitis, with only about half of treated eyes achieving 20/40 vision or better. 13 The visual outcome is worse in the presence of gram-negative bacteria 14 and those patients presenting with perception of light, 15 with less than 30% and 25% achieving 20/40 corrected visual acuity, respectively. In the current study, these adverse visual outcomes do not appear to be mirrored in terms of reduced survival rates. Indeed, in the current study, there did not appear to be an increased risk of death during the study period for patients who developed post-cataract endophthalmitis compared to a matched group of patients who did not develop this sightthreatening complication. This observation held for all age groups analysed and was not impacted by the presence or absence of viable infective organisms in the aqueous or vitreous samples. This finding is at variance for those patients diagnosed with endogenous endophthalmitis, where the mortality ranges from 5% to 38%, and is even higher when the infective organism isolated is Candida albicans.
10,11
In our series, approximately 65% of the patients with clinical endophthalmitis were culture positive, with Staphylococcus epidermidis being the most Figure 1 . Kaplan-Meier survival curves for cases of endophthalmitis and matched controls without endophthalmitis following cataract surgery. common organism isolated. Pseudomonas aeruginosa was the most common gram-negative bacterium; however, this occurred in only two eyes. One case of fungal endophthalmitis was identified -a 57-year-old Pacific Island Nation male who died some 67 months following surgery of undetermined cause. Increased mortality has been linked with both the development of cataract and cataract surgery. 16, 17 However, these associations continue to be disputed, and currently, a consensus does not exist. Greenberg et al. attempted to identify predictors of mortality following cataract surgery and found that age and recent hospitalizations were the main indicators; however, endophthalmitis was not considered. 18 Bjerrum et al. reported a mortality approximating 26% for patients in the first year following cataract surgery complicated by endophthalmitis, but this was only for those cases that did not have additional surgery for retinal detachment, removal of the intraocular lens or enucleation. 19 Interestingly, the survival probability following the first year for those patients was unchanged for some 13 years.
In the current study, we did not address the pattern of endophthalmitis prophylaxis for patients undergoing cataract surgery. Suffice to say the use of intracameral antibiotics was not widespread, and most patients were given a subconjunctival injection of a cephalosporin at the completion of surgery and were prescribed a broadspectrum antibiotic drop to use for 15 days following the surgery. 20 All patients in this study presenting with presumed post-cataract endophthalmitis were treated with intravitreal vancomycin and/or intravitreal amikacin or ceftazidine according to surgeon preference. None of the cases were resistant to vancomycin, which has been documented to be an independent predictor of death in some cases of bacteraemia. 21 Relhan et al. have recently reviewed all cases of endophthalmitis caused by grampositive organisms with reduced vancomycin susceptibility and highlighted both favourable and unfavourable outcomes in terms of function. 22 Re-examining the 18 studies referred to in that survey, patients with post-cataract endophthalmitis did not show any increased mortality, suggesting vancomycin-resistant organisms are not an indicator of life expectancy outcome.
The limitations of this study are that only 48 cases of endophthalmitis following cataract surgery were available for analysis over a 10-year period. Furthermore, the endophthalmitis group were also censored earlier than the control group as their cataract surgery was performed in more recent years. The survival would be more comparable if both the endophthalmitis and control groups had their surgeries and follow ups in the same time frame. However, it is evident from the survival curves that they follow a similar trend up to their median (50% cumulative survival), approximating 100 months. Accepting that limitation, the matched control group was from an identical geographic location and was operated on in a similar environment and, to a large extent, by the same pool of ophthalmic surgeons. Furthermore, despite being operated on in an earlier period, the cataract surgical techniques (e.g. corneal incision size) did not alter significantly in the two time frames. Neither surgeon nor surgical factors were considered in relation to endophthalmitis in the study group. Furthermore, we did not account for ethnicity or socioeconomic status. Finally, although the smoking history was available from the control group comprising the Auckland Cataract Study, we did not have this information for the patients who developed post-cataract endophthalmitis.
In conclusion, although the development of cataract, undergoing cataract surgery and the development of post-cataract endophthalmitis have all been hypothesized to be associated with increased mortality, the current case-control study demonstrated no difference in mortality rates between those with and those without endophthalmitis following cataract surgery.
